Targeting RNA structures by antisense oligonucleotides

Biochimie

Volumn 78, Issue 7, 1996, Pages 663-673

  Toulme J J ^a   Le Tinevez R ^a   Brossalina, E ^a,b  

^a INSERM   (France)

^b INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

Author keywords

Aptamer; Stem loop structure; Translation inhibition; Triple helix

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE;

ARTICLE; GENE EXPRESSION; GENE TARGETING; HUMAN; RNA STRUCTURE; TRIPLE HELIX; TRYPANOSOMA;

TRYPANOSOMA;

EID: 0029969884     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(96)80012-5     Document Type: Article

References (85)

1. Hélène C, Toulmé JJ. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta. 1049:1990;99-125.
2. Milligan JF, Matteucci MD, Martin JC. Current concepts in antisense drug design. J Med Chem. 36:1993;1923-1937.
3. Goodchild J. Conjugates of oligonucleotides and modified oligonucleotides: a review of their synthesis and properties. Bioconjugate Chem. 1:1990;165-187.
4. Zon G. Brief overview of control of genetic expression by antisense oligonucleotides and in vivo applications - prospects for neurobiology. Mol Neurobiol. 10:1995;219-229.
5. Chastain M, Tinoco I Jr. Structural elements in RNA. Progr Nucleic Acid Res Mol Biol. 41:1991;131-147.
6. Verspieren P, Loreau N, Thuong NT, Shire D, Toulmé JJ. Effect of RNA secondary structure and modified bases on the in vitro inhibition of trypanosomatid protein synthesis by antisense oligodeoxynucleotides. Nucleic Acids Res. 18:1990;4711-4717.
7. Vickers T, Ecker DJ. Enhancement of ribosomal frameshifting by oligonucleotides targeted to the HIV gag-pol region. Nucleic Acids Res. 20:1992;3945-3953.
8. Monia BP, Johnston JF, Ecker DJ, Zounes MA, Lima WF, Freier SM. Selective inhibition of mutant ha-ras messenger RNA expression by antisense oligonucleotides. J Biol Chem. 267:1992;19954-19962.
9. Duroux I, Godard G, Boidot-Forget M, Schwab G, Hélène C, Saison-Behmoaras T. Rational design of point mutation-selective antisense DNA targeted to codon 12 of Ha-ras mRNA in human cells. Nucleic Acids Res. 23:1995;3411-3418.
10. Goodchild J, Agrawal S, Civeira MP, Sarin PS, Sun D, Zamecnik PC. Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides. Proc Natl Acad Sci USA. 85:1988;5507-5511.
11. Peyman A, Helsberg M, Kretzschmar G, Mag M, Grabley S, Uhlmann E. Inhibition of viral growth by antisense oligonucleotides directed against the IE110 and the UL30 mRNA of herpes simplex virus type-1. Bio Chem Hoppe Seyler. 376:1995;195-198.
12. Cazenave C, Loreau N, Thuong NT, Toulmé JJ, Hélène C. Enzymatic amplification of translation inhibition of rabbit β - globin mRNA mediated by anti-messenger oligodeoxynucleotides covalently linked to intercalating agents. Nucleic Acids Res. 15:1987;4717-4736.
13. Walder RY, Walder JA. Role of RNase-H in hybrid-arrested translation by antisense oligonucleotides. Proc Natl Acad Sci USA. 85:1988;5011-5015.
14. Boiziau C, Kurfurst R, Cazenave C, Roig V, Thuong NT, Toulmé JJ. Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism. Nucleic Acids Res. 19:1991;1113-1119.
15. Gait MJ, Karn J. RNA recognition by the human immunodeficiency virus Tat and Rev proteins. TIBS. 18:1993;255-259.
16. Hatfield DL, Levin JG, Rein A, Oroszlan S. Translation supression in retroviral gene expression. Advances in virus research. 1992;193-239 Academic Press Inc.
17. Pantopoulos K, Johansson HE, Hentze MW. The role of the 5′ untranslated region of eukaryotic messenger RNAs in translation and its investigation using antisense technologies. Progr Nucleic Acid Res Mol Biol. 48:1994;181-238.
18. Shamoo Y, Tam A, Konigsberg WH, Williams KR. Translational repression by the bacteriophage-T4 gene-32 protein involves specific recognition of an RNA pseudoknot structure. J Mol Biol. 232:1993;89-104.
19. Hehl A, Vassella E, Braun R, Roditi I. A conserved stem loop structure in the 3′ untranslated region of procyclin messenger RNAs regulates expression in Trypanosoma brucei. Proc Natl Acad Sci USA. 91:1994;370-374.
20. Pollack JR, Ganem D. An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation. J Virol. 67:1993;3254-3263.
21. Knight JB, Si ZH, Stoltzfus CM. A base-paired structure in the avian sarcoma virus 5′ leader is required for efficient encapsidation of RNA. J Virol. 68:1994;4493-4502.
22. Lima WF, Monia BP, Ecker DJ, Freier SM. Implication of RNA structure on antisense oligonucleotide hybridization kinetics. Biochemistry. 31:1992;12055-12061.
23. Freier S. Hybridization: considerations affecting antisense drugs. Lebleu B, Crooke ST. Antisense Research and Applications. 1993;67-82 CRC, Boca Raton.
24. Asseline U, Delarue M, Lancelot G, Toulmé F, Thuong NT, Montenay-Garestier T, Hélène C. Nucleic acid-binding molecules with high affinity and base sequence specificity: intercalating agents covalently linked to oligodeoxynucleotides. Proc Natl Acad Sci USA. 81:1984;3297-3301.
25. Toulmé JJ, Krisch HM, Loreau N, Thuong NT, Hélène C. Specific inhibition of mRNA translation by complementary oligonucleotides covalently linked to intercalating agents. Proc Natl Acad Sci USA. 83:1986;1227-1231.
26. Lamond AI, Sproat BS. Antisense oligonucleotides made of 2′ - O-alkylRNA - their properties and applications in RNA biochemistry. FEBS Lett. 325:1993;123-127.
27. Boiziau C, Larrouy B, Sproat B, Toulmé JJ. Antisense 2′ - O-alkyl oligoribonucleotides are efficient inhibitors of reverse transcription. Nucleic Acids Res. 23:1995;64-71.
28. Gryaznov SM, Lloyd DH, Chen JK, Schultz RG, DeDionisio LA, Ratmeyer L, Wilson WD. Oligonucleotide N3′ - > P5′ phosphoramidates. Proc Natl Acad Sci USA. 92:1995;5798-5802.
29. Egholm M, Buchardt O, Christensen L, Behrens C, Freier SM, Driver DA, Berg RH, Kim SK, Norden B, Nielsen PE. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature. 365:1993;566-568.
30. Woo J, Meyer RB, Gamper HB. G/C-modified oligodeoxynucleotides with selective complementarity: synthesis and hybridization properties. Nucleic Acids Res. 24:1996;. in press.
31. Giles RV, Tidd DM. Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase-H using chimeric methylphosphonodiester/phosphodiester structures. Nucleic Acids Res. 20:1992;763-770.
32. Larrouy B, Blonski C, Boiziau C, Stuer M, Moreau S, Shire D, Toulmé JJ. RNase-H mediated inhibition of translation by antisense oligodeoxynucleotides: a way to improve specificity. Gene. 121:1992;189-194.
33. Larrouy B, Boiziau C, Sproat B, Toulmé JJ. High affinity or selectivity: a dilemma to design antisense oligodeoxynucleotides acting in RNaseH-containing media. Nucleic Acids Res. 23:1995;3434-3440.
34. Ecker DJ, Vickers TA, Bruice TW, Freier SM, Jenison RD, Manoharan M, Zounes M. Pseudo-half-knot formation with RNA. Science. 257:1993;958-961.
35. ten Dam E, Pleij K, Draper D. Structural and functional aspects of RNA pseudoknots. Biochemistry. 31:1992;11665-11676.
36. François JC, Thuong N, Hélène C. Recognition and cleavage of hairpin structures in nucleic acids by oligodeoxynucleotides. Nucleic Acids Res. 22:1994;3943-3950.
37. Cload ST, Schepartz A. Polyether tethered oligonucleotide probes. J Am Chem Soc. 113:1991;6324-6326.
38. Richardson PL, Schepartz A. Tethered oligonucleotide probes - A strategy for the recognition of structured RNA. J Am Chem Soc. 113:1991;5109-5111.
39. Cload ST, Richardson PL, Huang YH, Schepartz A. Kinetic and thermodynamic analysis of RNA binding by tethered oligonucleotide probes - alternative structures and conformational changes. J Am Chem Soc. 115:1993;5005-5014.
40. Takayama KM, Inouye M. Antisense RNA. Crit Rev Biochem Mol Biol. 25:1990;155-184.
41. Eguchi Y, Tomizawa JI. Complex formed by complementary RNA stem-loops and its stabilization by a protein: function of ColE1 Rom protein. Cell. 60:1990;199-209.
42. Chang KY, Tinoco I. Characterization of a `kissing' hairpin complex derived from the human immunodeficiency virus genome. Proc Natl Acad Sci USA. 91:1994;8705-8709.
43. Isel C, Ehresmann C, Keith G, Ehresmann B, Marquet R. Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA lys3 (template/primer) complex. J Mol Biol. 247:1995;236-250.
44. Skripkin E, Paillart JC, Marquet R, Ehresmann B, Ehresmann C. Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitro. Proc Natl Acad Sci USA. 91:1994;4945-4949.
45. Homann M, Rittner K, Sczakiel G. Complementary large loops determine the rate of RNA duplex formation in vitro in the case of an effective antisense RNA directed against the human immunodeficiency virus type-1. J Mol Biol. 233:1993;7-15.
46. Thuong NT, Hélène C. Sequence specific recognition and modification of double-helical DNA by oligonucleotides. Int Ed Engl Angew Chem. 32:1993;666-690.
47. Baumann U, Frank R, Blöcker H. Interaction of DNA hairpin loops and a complementary strand by a triplet of base pairs. Biochem Biophys Res Commun. 157:1988;986-991.
48. Svinarchuk F, Bertrand JR, Malvy C. A short purine oligonucleotide forms a highly stable triple helix with the promoter of the murine c-pim-1 proto-oncogene. Nucleic Acids Res. 22:1994;3742-3747.
49. Zhou BW, Puga E, Sun JS, Garestier T, Hélène C. Stable triple helices formed by acridine-containing oligonucleotides with oligopurine tracts of DNA interrupted by one or two pyrimidines. J Am Chem Soc. 117:1995;10425-10428.
50. Beal PA, Dervan PB. Recognition of double helical DNA by alternate strand triple helix formation. J Am Chem Soc. 114:1992;4976-4982.
51. Jayasena SD, Johnston BH. Intramolecular triple-helix formation at (PunPyn). (PunPyn) tracts. Recognition of alternate strands via Pu.PuPy and Py.PuPy base triplets. Biochemistry. 31:1992;320-327.
52. Brossalina E, Toulmé JJ. A DNA hairpin as a target for antisense oligonucleotides. J Am Chem Soc. 115:1993;796-797.
53. Brossalina E, Pascolo E, Toulmé JJ. The binding of an antisense oligonucleotide to a hairpin structure via triplex formation inhibits chemical and biological reactions. Nucleic Acids Res. 21:1993;5616-5622.
54. Moser HE, Dervan PB. Sequence-specific cleavage of double helical DNA by triple helix formation. Science. 238:1987;645-650.
55. Xodo LE, Manzini G, Quadrifoglio F, Vandermarel GA, Vanboom JH. Effect of 5-methylcytosine on the stability of triple-stranded DNA. A thermodynamic study. Nucleic Acids Res. 19:1991;5625-5631.
56. Wagner RW, Matteucci MD, Lewis JG, Gutierrez AJ, Moulds C, Froehler BC. Antisense gene inhibition by oligonucleotides containing C - 5 propyne pyrimidines. Science. 260:1993;1510-1513.
57. Michel J, Toulmé JJ, Vercauteren J, Moreau S. Quinazoline-2,4 (1H, 3H)-dione as a substitute for thymine in triple-helix forming oligonucleotides: a reassessment. Nucleic Acids Res. 24:1995;1127-1135.
58. Brossalina E, Demchenko E, Demchenko Y, Vlassov V, Toulmé JJ. Antisense oligonucleotide trigger conformation changes of a target sequence. Modulation of restriction nuclease activity. Nucleic Acids Res. 24:1996;3392-3398.
59. Roberts RW, Crothers DM. Stability and properties of double and triple helices - dramatic effects of RNA or DNA backbone composition. Science. 258:1992;1463-1466.
60. Han H, Dervan PB. Sequence-specific recognition of double helical RNA and RNA. DNA by triple helix formation. Proc Natl Acad Sci USA. 90:1993;3806-3810.
61. Escudé C, François JC, Sun JS, Ott G, Sprinzl M, Garestier T, Hélène C. Stability of triple helices containing RNA and DNA strands - experimental and molecular modeling studies. Nucleic Acids Res. 21:1993;5547-5553.
62. Gold L, Polisky B, Uhlenbeck O, Yarus M. Diversity of oligonucleotide functions. Annu Rev Biochem. 64:1995;763-797.
63. Pei D, Ulrich HD, Schultz PG. A combinatorial approach toward DNA recognition. Science. 253:1991;1408-1411.
64. Hardenbol P, van Dyke MW. Sequence specificty of triplex DNA formation: analysis by a combinatorial approach, restriction endonuclease protection selection and amplification. Proc Natl Acad Sci USA. 93:1996;2811-2816.
65. Cload ST, Schepartz A. Selection of structure-specific inhibitors of the HIV Rev-Rev response element complex. J Am Chem Soc. 116:1994;437-442.
66. Mishra RK, Toulmé JJ. In vitro selection of antisense oligonucleotides targeted to a hairpin structure. CR Acad Sci Paris. 317:1994;977-982.
67. Mishra RK, Le Tinévez R, Toulmé JJ. Targeting of nucleic acid secondary structures by antisense oligonucleotides designed through in vitro selection. Proc Natl Acad Sci USA. 1996;. in press.
68. Borst P. Discontinuous transcription and antigenic variation in trypanosomes. Annu Rev Biochem. 55:1986;701-732.
69. Laird PW, Kooter JM, Loosbroek N, Borst P. Mature mRNAs of Trypanosoma brucei possess a 5′ cap acquired by discontinuous transcription. Nucleic Acids Res. 13:1985;4253-4266.
70. Miller SI, Landfear SM, Wirth DF. Cloning and characterization of a Leishmania gene encoding a RNA spliced leader sequence. Nucleic Acids Res. 14:1986;7341-7360.
71. De Lange T, Berkvens TM, Veerman HJG, Frasch ACC, Barry JD, Borst P. Comparison of the genes coding for the common 5′ terminal sequence of messenger RNAs in three trypanosome species. Nucleic Acids Res. 12:1984;4431-4443.
72. Perry KL, Watkins KP, Agabian N. Trypanosome mRNAs have unusual cap 4 structures acquired by addition of a spliced leader. Proc Natl Acad Sci USA. 84:1987;8190-8194.
73. Cornelissen AWCA, Verspieren P, Toulmé JJ, Swinkels BW, Borst P. The common 5′ terminal sequence on trypanosome mRNAs: a target for anti-messenger oligodeoxynucleotides. Nucleic Acids Res. 14:1986;5605-5614.
74. Walder JA, Eder PS, Engman DM, Brentano ST, Walder RY, Knutzon DS, Dorfman DM, Donelson JE. The 35-nucleotide spliced leader sequence is common to all trypanosome messenger RNA. Science. 233:1986;569-571.
75. Pascolo E, Blonski C, Shire D, Toulmé JJ. Antisense effect of oligodeoxynucleotides complementary to the mini-exon sequence of the protozoan parasite Leishmania amazonensis. Biochimie. 75:1993;43-47.
76. Verspieren P, Cornelissen AWCA, Thuong NT, Hélène C, Toulmé JJ. An acridine-linked-oligodeoxynucleotide targeted to the common 5′ end of trypanosome mRNAs kills cultured parasites. Gene. 61:1987;307-315.
77. Ramazeilles C, Mishra RK, Moreau S, Pascolo E, Toulmé JJ. Antisense phosphorothioate oligonucleotides: selective killing of the intracellular parasite Leishmania amazonensis. Proc Natl Acad Sci USA. 91:1994;7859-7863.
78. Pascolo E, Hudrisier D, Sproat B, Thuong NT, Toulmé JJ. Relative contribution of photo-addition, helper oligonucleotide and RNase H to the antisense effect of psoralen-oligonucleotide conjugates on in vitro translatioin of Leishmania mRNAs. Biochim Biophys Acta. 1219:1994;98-106.
79. Kean JM, Miller PS. Effect of target structure on cross-linking by psoralen-derivatized oligonucleoside methylphosphonates. Biochemistry. 33:1994;9178-9186.
80. Porumb H, Verspieren P, Rayner B, Imbach JL, Malvy C, Toulmé JJ. Measurement by thermoelution of the stability of duplexes formed by nucleic acids and their nucleic acids target. Methods Mol Cell Biol. 4:1992;10-21.
81. Toulmé JJ, Cazenave C, Moreau S. Selecting, preparing and handling an antisense oligonucleotide sequence. Lichtenstein C, Nellen W. Antisense technology: a practical approach. 1996;Oxford University Press, Oxford. in press.
82. Best GC, Dervan PB. Energetics of formation of sixteen triple helical complexes which vary at a single position within a pyrimidine motif. J Am Chem Soc. 117:1995;1187-1193.
83. Griffin LC, Dervan PB. Recognition of thymine-adenine base pairs by guanine in a pyrimidine triple helix motif. Science. 245:1989;967-971.
84. Yoon K, Hobbs CA, Koch J, Sardaro M, Kutny R, Weis AL. Elucidation of the sequence-specific 3rd-strand recognition of 4 Watson-Crick base pairs in a pyrimidine triple-helix motif. T-•-AT, C-•-GC, T-•-CG, and G-•-TA. Proc Natl Acad Sci USA. 89:1992;3840-3844.
85. Mergny JL, Sun JS, Rougée M, Montenay-Garestier T, Barcelo F, Chomilier J, Hélène C. Sequence specificity in triple-helix formation. Experimental and theoretical studies of the effect of mismatches on triplex stability. Biochemistry. 30:1991;9791-9798.